Clinical Trials Browser

Interventional × Denosumab × Gynecologic × Clear all

NCT06513624 2025-07-25

ETC-159-02

Phase 1 Recruiting

With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer

NCT03382574 2022-06-14

Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-Oophorectomy

Phase EARLY_PHASE1 Terminated

Ovarian Neoplasms